Few Want to Receive Skin Cancer Biopsy Results Face-to-Face

This article originally appeared here.
Share this content:
Few Want to Receive Skin Cancer Biopsy Results Face-to-Face
Few Want to Receive Skin Cancer Biopsy Results Face-to-Face

FRIDAY, Feb. 12, 2016 (HealthDay News) -- For patients with suspected malignant melanoma or squamous cell carcinoma, most patients are happy to receive biopsy results by letter or telephone, according to a research letter published online Feb. 8 in the British Journal of Dermatology.

Nicola Cooke and Graham B. Colver, B.M., B.Ch., from the Chesterfield Royal Hospital NHS Foundation Trust in the United Kingdom, explored communication methods for conveying a diagnosis of skin cancer to patients. They recruited 77 patients with suspected malignant melanoma or squamous cell carcinoma. Clinicians explained that patients would receive diagnosis by telephone, letter, or face-to-face after biopsy; patients were offered a leaflet discussing the implications of a cancer diagnosis. Patients were reminded of the three alternatives when they attended for their diagnostic biopsy and their choice was recorded. Patients were surveyed one month after receiving their biopsy results regarding their satisfaction with communication methods.

The researchers found that 47, 37, 11, and 5 percent of respondents had chosen to receive their diagnosis by letter, telephone, face-to-face, or a combination of two methods, respectively. Eighty-nine percent of respondents received their results in the manner they had selected. Overall, 94 percent of patients were happy with the way they received their diagnosis. Eighty percent of participants were happy with their original choice of communication method, and only 11 percent reported that they would have preferred a different method.

"Conveying bad news in a face-to-face meeting may not be best for every skin cancer patient," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »